These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. Kassell NF; Torner JC; Adams HP J Neurosurg; 1984 Aug; 61(2):225-30. PubMed ID: 6737046 [TBL] [Abstract][Full Text] [Related]
7. Prevention of early rebleeding. Iplikçioglu AC; Bek S J Neurosurg; 2003 May; 98(5):1147; author reply 1148. PubMed ID: 12744386 [No Abstract] [Full Text] [Related]
8. Prevention of early rebleeding. Roos Y; Vermeulen M J Neurosurg; 2003 May; 98(5):1148-9; author reply 1149-50. PubMed ID: 12744388 [No Abstract] [Full Text] [Related]
9. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Roos Y Neurology; 2000 Jan; 54(1):77-82. PubMed ID: 10636129 [TBL] [Abstract][Full Text] [Related]
10. Effect of short-term ε-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage. Malekpour M; Kulwin C; Bohnstedt BN; Radmand G; Sethia R; Mendenhall SK; Weyhenmeyer J; Hendricks BK; Leipzig T; Payner TD; Shah MV; Scott J; DeNardo A; Sahlein D; Cohen-Gadol AA J Neurosurg; 2017 May; 126(5):1606-1613. PubMed ID: 27315025 [TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Gaberel T; Magheru C; Emery E; Derlon JM Acta Neurochir (Wien); 2012 Jan; 154(1):1-9; discussion 9. PubMed ID: 22002504 [TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage. Kassell NF; Haley EC; Torner JC Clin Neurosurg; 1986; 33():137-45. PubMed ID: 3491721 [TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. Leipzig TJ; Redelman K; Horner TG J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423 [TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Roos Y; Rinkel G; Vermeulen M; Algra A; van Gijn J Stroke; 2003 Sep; 34(9):2308-9. PubMed ID: 12933970 [No Abstract] [Full Text] [Related]
15. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Harrigan MR; Rajneesh KF; Ardelt AA; Fisher WS Neurosurgery; 2010 Oct; 67(4):935-9; discussion 939-40. PubMed ID: 20881558 [TBL] [Abstract][Full Text] [Related]
16. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. Larsen CC; Astrup J World Neurosurg; 2013 Feb; 79(2):307-12. PubMed ID: 22722033 [TBL] [Abstract][Full Text] [Related]
17. Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study. Pinna G; Pasqualin A; Vivenza C; Da Pian R Acta Neurochir (Wien); 1988; 93(3-4):77-87. PubMed ID: 3177035 [TBL] [Abstract][Full Text] [Related]
18. Prevention of early rebleeding. Lanzino G; Wang H J Neurosurg; 2003 May; 98(5):1146-7; author reply 1148. PubMed ID: 12744385 [No Abstract] [Full Text] [Related]
19. Prevention of early rebleeding. Schisano G; Nina P J Neurosurg; 2003 May; 98(5):1147-8; author reply 1148. PubMed ID: 12744387 [No Abstract] [Full Text] [Related]
20. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study. Foreman PM; Chua M; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ Clin Neurol Neurosurg; 2015 Dec; 139():66-9. PubMed ID: 26378393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]